Updates from the National Institutes of Health onCOVID-19 Funding and Funding OpportunitiesPosted on April 13, 2020 by NIH Deputy Director for Extramural Research Dr. Michael Lauer As you can imagine, NIH is devoting significant resources to COVID-19. In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills (available from the NIH Office of Budget website), that together provide:
To get funding as quickly as possible to the research community, we are using Urgent and Emergency competing revisions and administrative supplements to existing grant awards. This approach allows us to leverage resident expertise, getting additional funding to those researchers who are already working with other organisms, models, or tools so that they can quickly shift focus to the novel coronavirus. These Urgent and Emergency competitive revision Funding Opportunity Announcements (FOAs) allow NIH to fund applications quickly, often in under three months, sometimes much quicker than that, because evaluation for scientific and technical merit is done by an internal review panel convened by staff of the NIH awarding institute or center rather than by our traditional peer review process. The Urgent and Emergency competing revision FOAs sound very similar. And they are, but there is an important distinction.
When responding to these types of funding opportunities, it is important that you understand how they work.
NIH is issuing new COVID-19 related NOSIs frequently. Please check back for these and other COVID-19-related information on our Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding website. You can learn more about NOSI’s in this quick 5 minute video. https://www.youtube.com/watch?v=LhXW67LNbIc&feature=youtu.be |